Zacks: Analysts Anticipate UnitedHealth Group Incorporated (NYSE:UNH) Will Announce Earnings of $4.30 Per Share

Wall Street analysts expect that UnitedHealth Group Incorporated (NYSE:UNH) will report $4.30 earnings per share for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for UnitedHealth Group’s earnings. The highest EPS estimate is $4.36 and the lowest is $4.25. UnitedHealth Group reported earnings of $2.52 per share during the same quarter last year, which indicates a positive year-over-year growth rate of 70.6%. The business is scheduled to report its next quarterly earnings results on Wednesday, January 19th.

On average, analysts expect that UnitedHealth Group will report full-year earnings of $18.85 per share for the current year, with EPS estimates ranging from $18.79 to $18.90. For the next fiscal year, analysts anticipate that the company will post earnings of $21.69 per share, with EPS estimates ranging from $21.20 to $22.02. Zacks’ earnings per share averages are an average based on a survey of research analysts that that provide coverage for UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, topping analysts’ consensus estimates of $4.41 by $0.11. The company had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. UnitedHealth Group’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.51 EPS.

Several research firms have commented on UNH. BMO Capital Markets boosted their price objective on UnitedHealth Group from $435.00 to $475.00 and gave the stock a “market perform” rating in a research note on Monday, October 18th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $421.00 to $477.00 and gave the stock a “buy” rating in a research note on Tuesday, November 16th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 price objective for the company in a research note on Wednesday, October 27th. Oppenheimer boosted their price objective on UnitedHealth Group from $465.00 to $475.00 and gave the stock an “outperform” rating in a research note on Friday, October 15th. Finally, Wells Fargo & Company upped their price target on UnitedHealth Group from $478.00 to $520.00 and gave the company an “overweight” rating in a research report on Monday, October 25th. One analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $477.35.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of the company’s stock in a transaction on Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction on Friday, September 17th. The shares were sold at an average price of $419.00, for a total value of $1,047,500.00. The disclosure for this sale can be found here. Insiders sold 82,500 shares of company stock valued at $36,855,125 over the last quarter. 0.55% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. raised its stake in shares of UnitedHealth Group by 1.0% in the third quarter. BlackRock Inc. now owns 69,706,545 shares of the healthcare conglomerate’s stock valued at $27,237,133,000 after acquiring an additional 679,255 shares in the last quarter. FMR LLC raised its stake in UnitedHealth Group by 0.6% in the second quarter. FMR LLC now owns 50,452,463 shares of the healthcare conglomerate’s stock valued at $20,203,185,000 after buying an additional 291,660 shares in the last quarter. State Street Corp raised its stake in UnitedHealth Group by 1.9% in the second quarter. State Street Corp now owns 44,530,535 shares of the healthcare conglomerate’s stock valued at $17,831,807,000 after buying an additional 838,941 shares in the last quarter. Capital World Investors raised its stake in UnitedHealth Group by 0.4% in the third quarter. Capital World Investors now owns 34,268,409 shares of the healthcare conglomerate’s stock valued at $13,390,353,000 after buying an additional 149,756 shares in the last quarter. Finally, EP Wealth Advisors LLC raised its stake in UnitedHealth Group by 49,050.0% in the third quarter. EP Wealth Advisors LLC now owns 15,517,624 shares of the healthcare conglomerate’s stock valued at $11,590,000 after buying an additional 15,486,052 shares in the last quarter. Institutional investors and hedge funds own 86.20% of the company’s stock.

NYSE:UNH opened at $450.16 on Friday. UnitedHealth Group has a 12 month low of $320.35 and a 12 month high of $466.00. The stock has a 50 day moving average of $430.47 and a two-hundred day moving average of $418.01. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.59. The firm has a market cap of $423.98 billion, a P/E ratio of 27.93, a price-to-earnings-growth ratio of 1.75 and a beta of 0.85.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 14th. Investors of record on Monday, December 6th will be given a $1.45 dividend. The ex-dividend date is Friday, December 3rd. This represents a $5.80 annualized dividend and a yield of 1.29%. UnitedHealth Group’s payout ratio is 35.98%.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Recommended Story: Outstanding Shares

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.